On April 13, 2021, BCTG Acquisition Corp. (“BCTG”), entered into an agreement and plan of merger by and among BCTG, BCTG Merger Sub Inc. and a wholly-owned subsidiary of BCTG (“Merger Sub”), and Tango Therapeutics Inc. (“Tango”). Immediately following the closing, BCTG’s board of directors will consist of nine directors, consisting of Barbara Weber, Reid Huber, Alexis Borisy, Malte Peters, Aaron Davis, Mace Rothenberg and Lesley Calhoun. At the closing, all of the executive officers of BCTG shall resign and the individuals serving as executive officers of BCTG immediately after the closing will be the same individuals (in the same offices) as those of Tango immediately prior to the closing.